KR970704668A - 다이머 DTPA 유도체 및 이들의 금속 착물, 이들을 함유하는 약제, 진단 및 치료법에 있어서의 이들의 용도, 및 상기 착물 약제의 제조 방법(Dimer DTPA Derivatives and Their Metal Complexes, Pharmaceuticals Containing the Same, Their Use in Diagnosis and Therapy and Process for Preparing Said Complexes and Pharmaceuticals) - Google Patents

다이머 DTPA 유도체 및 이들의 금속 착물, 이들을 함유하는 약제, 진단 및 치료법에 있어서의 이들의 용도, 및 상기 착물 약제의 제조 방법(Dimer DTPA Derivatives and Their Metal Complexes, Pharmaceuticals Containing the Same, Their Use in Diagnosis and Therapy and Process for Preparing Said Complexes and Pharmaceuticals) Download PDF

Info

Publication number
KR970704668A
KR970704668A KR1019970700944A KR19970700944A KR970704668A KR 970704668 A KR970704668 A KR 970704668A KR 1019970700944 A KR1019970700944 A KR 1019970700944A KR 19970700944 A KR19970700944 A KR 19970700944A KR 970704668 A KR970704668 A KR 970704668A
Authority
KR
South Korea
Prior art keywords
bis
carboxymethyl
group
complex
salt
Prior art date
Application number
KR1019970700944A
Other languages
English (en)
Korean (ko)
Inventor
베르너 크라우제
프란쯔-칼 마이어
미카엘 바우어
볼프-뤼디거 프레스
가브리엘레 슈만-기암피리
요하네스 플라쩨크
헤리베르트 슈미트-빌리히
Original Assignee
마거, 우베 하르트만
쉐링 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마거, 우베 하르트만, 쉐링 악티엔게젤샤프트 filed Critical 마거, 우베 하르트만
Publication of KR970704668A publication Critical patent/KR970704668A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
KR1019970700944A 1994-08-08 1995-08-08 다이머 DTPA 유도체 및 이들의 금속 착물, 이들을 함유하는 약제, 진단 및 치료법에 있어서의 이들의 용도, 및 상기 착물 약제의 제조 방법(Dimer DTPA Derivatives and Their Metal Complexes, Pharmaceuticals Containing the Same, Their Use in Diagnosis and Therapy and Process for Preparing Said Complexes and Pharmaceuticals) KR970704668A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4428874A DE4428874A1 (de) 1994-08-08 1994-08-08 Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
DEP4428874.3 1994-08-08
PCT/EP1995/003142 WO1996005167A1 (de) 1994-08-08 1995-08-08 Dimere dtpa-derivate und deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie sowie verfahren zur herstellung der komplexe und mittel

Publications (1)

Publication Number Publication Date
KR970704668A true KR970704668A (ko) 1997-09-06

Family

ID=6525715

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970700944A KR970704668A (ko) 1994-08-08 1995-08-08 다이머 DTPA 유도체 및 이들의 금속 착물, 이들을 함유하는 약제, 진단 및 치료법에 있어서의 이들의 용도, 및 상기 착물 약제의 제조 방법(Dimer DTPA Derivatives and Their Metal Complexes, Pharmaceuticals Containing the Same, Their Use in Diagnosis and Therapy and Process for Preparing Said Complexes and Pharmaceuticals)

Country Status (21)

Country Link
US (1) US5695737A (zh-CN)
EP (1) EP0775104B1 (zh-CN)
JP (1) JPH10503777A (zh-CN)
KR (1) KR970704668A (zh-CN)
AT (1) ATE179696T1 (zh-CN)
AU (1) AU695878B2 (zh-CN)
CA (1) CA2197074A1 (zh-CN)
CZ (1) CZ40597A3 (zh-CN)
DE (2) DE4428874A1 (zh-CN)
DK (1) DK0775104T3 (zh-CN)
ES (1) ES2134487T3 (zh-CN)
FI (1) FI970535A0 (zh-CN)
GR (1) GR3030827T3 (zh-CN)
HU (1) HUT77532A (zh-CN)
IL (1) IL114858A0 (zh-CN)
MX (1) MX9701080A (zh-CN)
NO (1) NO970602L (zh-CN)
PL (1) PL318503A1 (zh-CN)
SK (1) SK17397A3 (zh-CN)
WO (1) WO1996005167A1 (zh-CN)
ZA (1) ZA956650B (zh-CN)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
IT1290417B1 (it) * 1996-08-02 1998-12-03 Bracco Spa Composti chelanti derivati di acidi poliamminopolicarbossilici, loro chelati con ioni metallici paramagnetici, loro preparazione ed
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
CA2309749A1 (en) 1997-11-17 1999-05-27 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
WO2002006287A2 (en) 2000-07-17 2002-01-24 California Institute Of Technology Macrocyclic mri contrast agents
WO2002028441A2 (en) 2000-10-04 2002-04-11 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4915933A (en) * 1986-06-26 1990-04-10 The University Of New Mexico Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2652004B1 (fr) * 1989-09-21 1994-10-28 Immunotech Partners Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques.
US5244816A (en) * 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
ES2116291T3 (es) * 1989-10-23 1998-07-16 Nycomed Salutar Inc Agentes quelantes de metales en sitios multiples.
WO1992005804A1 (en) * 1990-09-27 1992-04-16 Brunswick Corporation Chelating agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5466439A (en) * 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images

Also Published As

Publication number Publication date
FI970535A (fi) 1997-02-07
ZA956650B (en) 1996-03-19
CZ40597A3 (en) 1997-07-16
ATE179696T1 (de) 1999-05-15
AU3343395A (en) 1996-03-07
DE59505856D1 (de) 1999-06-10
DK0775104T3 (da) 2000-01-03
US5695737A (en) 1997-12-09
EP0775104A1 (de) 1997-05-28
GR3030827T3 (en) 1999-11-30
MX9701080A (es) 1997-05-31
JPH10503777A (ja) 1998-04-07
CA2197074A1 (en) 1996-02-22
SK17397A3 (en) 1997-11-05
IL114858A0 (en) 1995-12-08
NO970602D0 (no) 1997-02-10
EP0775104B1 (de) 1999-05-06
HUT77532A (hu) 1998-05-28
WO1996005167A1 (de) 1996-02-22
DE4428874A1 (de) 1996-02-22
AU695878B2 (en) 1998-08-27
FI970535A0 (fi) 1997-02-07
NO970602L (no) 1997-02-10
PL318503A1 (en) 1997-06-23
ES2134487T3 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
KR970704668A (ko) 다이머 DTPA 유도체 및 이들의 금속 착물, 이들을 함유하는 약제, 진단 및 치료법에 있어서의 이들의 용도, 및 상기 착물 약제의 제조 방법(Dimer DTPA Derivatives and Their Metal Complexes, Pharmaceuticals Containing the Same, Their Use in Diagnosis and Therapy and Process for Preparing Said Complexes and Pharmaceuticals)
US5281704A (en) Polychelant compounds
DK171352B1 (da) Metalkomplekser og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser samt diagnostiske midler og farmaceutiske præparater indeholdende forbindelserne
AU612119B2 (en) Amide complexes
RU2539565C2 (ru) Са-ix специфические радиофармпрепараты для лечения и визуалазиции злокачественных опухолей
US5446145A (en) Polychelant compounds
AU656689B2 (en) Multi-site metal chelating agents
US5679810A (en) Linear oligomeric polychelant compounds
JP2016506916A (ja) Ｂｃｌ−２／Ｂｃｌ−ｘＬ阻害薬およびそれを使用した治療方法
JPH07507994A (ja) Ｎ，ｎ’−ジ置換グアニジン類およびそれらの興奮性アミノ酸拮抗剤としての用途
Kasina et al. Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals
DE69123697T2 (de) Peptidverbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP1200395A1 (en) Urea derivatives as inhibitors of ccr-3 receptor
US5409689A (en) MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
IL100698A (en) Polyamine Theolytes and anti-radiation drugs containing them
KR880011082A (ko) β-아미노 에틸-치환된 페닐 화합물 및 그들의 약제학적으로 허용되는 염 및 아미드
EP0739200A1 (en) Therapeutic substituted guanidines
RU2002118700A (ru) Замещенные производные норборниламина, способ их получения, их применение в качестве медикаментов или диагностических средств, а также содержащие их медикаменты
CA1327969C (en) Substituted amine derivatives, their production and use
KR890006228A (ko) 항종양제로서 폴리아민 유도체
RU2003132539A (ru) Производные щавелевой кислоты
JPH01261383A (ja) アルキレンジアミン誘導体
EP0454078A2 (en) Dual functioning excipient for metal chelate contrast agents
EP0543482A1 (en) Aminocarboxylate ligands having substituted aromatic amide moieties
RU2113431C1 (ru) Аналоги 15-дезоксиспергуалина, способ их получения, способ получения промежуточных соединений (варианты), аминозащищенные соединения в качестве промежуточных соединений и фармацевтическая композиция на основе аналогов 15-дезоксиспергуалина

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid